From: MicroRNA genetic signature in non-small cell lung cancer (NSCLC) Egyptian patients
mi RNA | Log (fold change) (mean ± sd) | p value | |
---|---|---|---|
Control | NSCLC patients | ||
miR-16-5b | 0.22 ± 0.01 | 0.03 ± 0.01 | 0.001* |
miR-17b-5p | 3.05 ± 0.02 | 2.40 ± 18 | 0.001* |
miR-19-3p | ± 2.170.07 | − 0.02 ± 0.012 | 0.001* |
miR-20a-5p | 0.19 ± 0.06 | − 0.18 ± 0.017 | 0.001* |
miR-339-5p | 0.53 ± 0.29 | 0.06 ± 0.02 | 0.001* |
miR-146a | 0.55 ± 0.02 | 0.05 ± 0.03 | 0.001* |
let-7 g | 0.55 ± 0.03 | 0.08 ± 0.03 | 0.001* |
let-7a | 5.16 ± 0.09 | 2.42 ± 0.37 | 0.001* |
let-7c | 6.92 ± 0.01 | 3.05 ± 0.03 | 0.001* |
let-7e | 7.41 ± 0.82 | 3.80 ± 0.04 | 0.001* |
let-7f | 0.34 ± 0.08 | − 0.04 ± 0.03 | 0.001* |
let-7d | 4.77 ± 0.23 | 1.52 ± 0.19 | 0.001* |
let-7i | 0.93 ± 0.03 | 0.37 ± 0.05 | 0.001* |
miR-15a | 0.20 ± 0.25 | − 0.01 ± 0.002 | 0.001* |
195 MiR- | 0.22 ± 0.03 | − 0.04 ± 0.03 | 0.001* |
miR-98 | 1.31 ± 0.14 | − 0.05 ± 0.03 | 0.001* |
miR20b | 0.31 ± 0.07 | − 0.19 ± 0.10 | 0.001* |
miR-126- | 0.24 ± 0.06 | − 0.06 ± 0.03 | 0.001* |
miR-486-5p | 4.49 ± 0.14 | 2.40 ± 0.16 | 0.001* |